Angiotensin type I receptor antagonists CV-11974 and EXP 3174 cause selective renal vasodilatation in conscious spontaneously hypertensive rats

Clinical Science

Volumn 91, Issue 2, 1996, Pages 147-154

  Li, Xiao C ^a   Widdop, Robert E ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin II; Antagonists; AT1 receptors; CV 11974; EXP 3174; Renal vasodilatation; Spontaneously hypertensive rats

Indexed keywords

2 BUTYL 4 CHLORO 1 [[2' (1H TETRAZOL 5 YL) 4 BIPHENYLYL]METHYL] 5 IMIDAZOLECARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BENZIMIDAZOLE DERIVATIVE; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; SHORT SURVEY; SPONTANEOUSLY HYPERTENSIVE RAT; VASOCONSTRICTION; VASODILATATION; ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; KIDNEY CIRCULATION; WISTAR KYOTO RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; IMIDAZOLES; MALE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ANGIOTENSIN; RENAL CIRCULATION; TETRAZOLES; VASODILATION;

EID: 0029736670     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0910147     Document Type: Short Survey

References (36)

1. Timmermans PBMWM, Wong PC, Chiu AT, et al. Angiotensin II receptors and angiotensin II receptor agonists. Pharmacol Rev 1993; 45: 205-51.
2. Steckelings UM, Bottari P, Unger T. Angiotensin receptor subtypes in the brain. Trends Pharmacol Sci 1992; 13: 365-8.
3. Timmermans, PBMWM, Wong PC , Chiu AT, Herblin WF. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci 1991; 12: 55-62
4. Weber MA. Clinical experience with the angiotensin II receptor antagonist losartan: a preliminary report. Am J Hypertens 1992; 5: 247-51s.
5. Brunner HR, Christen Y, Munafo A, Lee RJ, Waeber B, Nussberger J. Clinical experience with angiotensin II receptor antagonists. Am J Hypertens 1992; 5: 243-6s.
6. Bunkenburg B, Schnell C, Baum HP, Cumin F, Wood JM. Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hypertension 1991; 18: 278-88.
7. Wong PC, Price WA, Chiu AT, et al. Hypotensive action of DuP 753. an angiotensin II antagonist, in spontaneously hypertensive rats. Hypertension 1990; 15: 459-68.
8. Campbell J. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79: 1-6.
9. Dzau VJ. Significance of the vascular renin-angiotensin pathway. Hypertension 1986; 8: 553-9.
10. Mizuno K, Tani M, Niimura S, Fukuchi S. Effect of delapril on the vascular angiotensin II release in isolated hindlegs of the spontaneously hypertensive rat: Evidence for potential relevance of vascular angiotensin II to the maintenance of hypertension. Clin Exp Pharmacol Physiol 1991; 18: 619-25.
11. Okunishi H, Kawamoto T, Kurobe Y. et al. Pathogenic role of vascular angiotensin-converting enzyme in the spontaneously hypertensive rat. Clin Exp Pharmacol Physiol 1991; 18: 649-59.
12. Arendshorst WJ, Chatziantoniou C, Daniels FH. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension. Kidney Int 1990; 31 (Suppl. 30): S92-6.
13. Chatziantoniou C, Arendshorst WJ. Angiotensin and thromboxane in genetically hypertensive rats: renal blood flow and receptor studies. Am J Physiol 1991; 261: F238-47.
14. Chatziantoniou C, Arendshorst WJ. Angiotensin receptor sites ir renal vasculature of rats developing genetic hypertension. Am J Physiol 1993; 265: F853-62.
15. Kost CK, Jackson EK. Enhanced renal angiotensin II subtype I receptor responses in the spontaneously hypertensive rat. Hypertension 1993; 21: 420-31.
16. Kost CK, Herzer WA, Li P, Jackson EK. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther 1994; 269: 82-8.
17. Bovee KC, Wong PC, Timmermans PBMWM, Thoolen MJMC. Effects of the nonpeptide angiotensin II receptor antagonist DuP 753 on blood pressure and renal functions in spontaneously hypertensive dogs. Am J Hypertens 1991; 4: 327S-33S.
18. Chan DP, Sandok EK, Aarhus LL, Heublein DM, Burnett JC. Renal-specific actions of angiotensin II receptor antagonism in the anaesthetised dog. Am J Hypertens 1992; 5: 354-60.
19. Fenoy FJ, Milici I, Smith RD, et al. Effects of DuP 753 on renal function of normotensive and spontaneously hypertensive rats. Am J Hypertens 1991; 4: 321S-6S.
20. Macari D, Bottari S, Whitebread S, De Gasparo M, Levens, N. Renal effects of CGP 42112 and PD 123319 in the sodium-depleted rat. Eur J Pharmacol 1993; 249: 85-93.
21. Batin P, Gardiner SM, Compton AM, Bennett T. Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in conscious, water-deprived, Brattleboro rats. Life Sci 1991; 48: 733-9.
22. Widdop RE, Gardiner SM, Kemp PA, Bennett T. Comparison of the regional haemodynamic effects of the ATI-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats. Br J Pharmacol 1993; 108: 684-8.
23. Inada Y, Wada T, Shibouta Y, et al. Antihypertensive effects of highly potent and long-acting angiotensin II subtype-I receptor antagonist (±)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidizole-7-carboxylate (TCV-116) in various hypertensive rats. J Pharmacol Exp Ther 1994; 268: 1540-7.
24. Noda M, Shibouta Y, Inada Y, et al. Inhibition of rabbit aortic angiotensin II (All) receptor by CV-11974, a new nonpeptide All antagonist. Biochem Pharmacol 1993; 46: 311-18.
25. Shibout, Y, Inada Y, Ojima M, et al. 1993; Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimiduole-7- carboxylic acid (CV-11974), and its prodrug, (±)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylate (TCV-116). J Pharmacol Exp Ther 266: 114-20.
26. Widdop RE, Li XC, Jarrott B. Regional haemodynamic effects of the novel ATI receptor antagonist, CV-11974, in conscious rats. Blood Pressure 1994; 3 (Suppl. 5): 15-20.
27. Widdop RE, Gardiner SM, Kemp PA, Bennett T. Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the ATI-receptor antagonist, EXP 3174. Br J Pharmacol 1992; 107: B73-80.
28. Haywood JR, Shaffer RA, fastenow C, Fink GD, Brody W. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol 1981; 241: H273-8.
29. Gardiner SM, Bennett T, Compton AM. Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious unrestrained, Long Evans and Brattleboro rats. J Auton Nervous System 1988; 24: 15-27.
30. Bartholomeusz B, Widdop RE. Effect of acute and chronic treatment with the angiotensin II subtype I receptor antagonist EXP 3174 on baroreflex function in conscious spontaneously hypertensive rats. J Hypertens 1995; 13: 219-25.
31. Takishita S, Muratani H, Sesoko S, et al. Short-term effects of angiotensin II blockade on renal blood flow and sympathetic activity in awake rats. Hypertension 1994; 24: 445-50.
32. Wood JM, Schnell CR, Levens NR. Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats. Hypertension 1993; 21: 1056-61.
33. Batin P, Gardiner SM, Compton AM, Kemp PA, Bennett T. Cardiac haemodynamic effects of the nonpeptide angiotensin II receptor antagonist. DuP 753, in conscious Long Evans and Brattleboro rats. Br J Pharmacol 1991; 103: 1585-91
34. Arendshorst WJ. Autoregulation of renal blood flow in spontaneously hypertensive rats. Circ Res 1979; 44: 344-9.
35. Trippodo NC, Frohlich ED Similarities of genetic (spontaneous) hypertension: man and rats. Circ Res 1981; 48: 309-19.
36. Li XC, Widdop RE. Regional haemodynamic effects of the AT, receptor antagonist CV-11974 in conscious renal hypertensive rats. Hypertension 1995; 26: 989-97.